Morgan Stanley’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.83M | Sell |
|
|||||
|
2025
Q1 | $7.64M | Buy |
|
|||||
|
2024
Q4 | $7.48M | Buy |
|
|||||
|
2024
Q3 | $7.44M | Sell |
|
|||||
|
2024
Q2 | $8.28M | Sell |
|
|||||
|
2024
Q1 | $12.4M | Sell |
|
|||||
|
2023
Q4 | $26.6M | Buy |
|
|||||
|
2023
Q3 | $1.26M | Sell |
|
|||||
|
2023
Q2 | $2.04M | Sell |
|
|||||
|
2023
Q1 | $2.67M | Sell |
|
|||||
|
2022
Q4 | $5.68M | Sell |
|
|||||
|
2022
Q3 | $8.43M | Buy |
|
|||||
|
2022
Q2 | $2.5M | Buy |
|
|||||
|
2022
Q1 | $128K | Sell |
|
|||||
|
2021
Q4 | $153K | Buy |
|
|||||
|
2021
Q3 | $68K | Buy |
|
|||||
|
2021
Q2 | $62K | Sell |
|
|||||
|
2021
Q1 | $572K | Sell |
|
|||||
|
2020
Q4 | $10.4M | Buy |
|
|||||
|
2020
Q3 | $109K | Buy |
|
|||||
|
2020
Q2 | $5K | Sell |
|
|||||
|
2020
Q1 | $8K | Sell |
|
|||||
|
2019
Q4 | $78K | Sell |
|
|||||
|
2019
Q3 | $169K | Buy |
|
|||||
|
2019
Q2 | $113K | Sell |
|
|||||
|
2019
Q1 | $288K | Sell |
|
|||||
|
2018
Q4 | $390K | Buy |
|
|||||
|
2018
Q3 | $208K | Sell |
|
|||||
|
2018
Q2 | $361K | Sell |
|
|||||
|
2018
Q1 | $2.37M | Buy |
|